Nicola Guzzi
Biopharmaceuticals R&D AstraZeneca, Mölndal
Goeteborg, O 43183, Sweden
Goeteborg, O 43183, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multimeric Conjugates Using Engineered Peptide Scaffolds for Efficient siRNA Delivery.
Journal: Bioconjugate chemistry
Published: May 30, 2025
RNA modifications at the heart of oral inflammation.
Journal: Molecular therapy. Nucleic acids
Published: April 24, 2025
PUS10-induced tRNA fragmentation impacts retrotransposon-driven inflammation.
Journal: Cell reports
Published: August 01, 2024
A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia.
Journal: Cell reports
Published: October 28, 2022
Quantitative analysis of redox proteome reveals oxidation-sensitive protein thiols acting in fundamental processes of developmental hematopoiesis.
Journal: Redox biology
Published: April 08, 2022
The integrated stress response remodels the microtubule-organizing center to clear unfolded proteins following proteotoxic stress.
Journal: eLife
Published: February 10, 2022
Author Correction: Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation.
Journal: Nature cell biology
Published: January 05, 2022
Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome.
Journal: Nature cell biology
Published: December 07, 2020
Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation.
Journal: Nature cell biology
Published: April 03, 2020
Novel insights into the emerging roles of tRNA-derived fragments in mammalian development.
Journal: RNA biology
Published: March 03, 2020
Last Updated: 09/26/2026